{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:29:07Z","timestamp":1790180947430,"version":"4.1.0"},"reference-count":96,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Asthma is a complex, heterogeneous disease characterised by clinical phenotypes demonstrating distinct and overlapping immunological mechanisms, classified into type\u20102 high and type\u20102 low asthma endotypes. Both allergic and eosinophilic non\u2010allergic asthma are driven through an underlying type\u20102 high\u2010endotype, which can be targeted using therapeutic approaches such as allergen\u2010specific immunotherapy (AIT) for allergic asthma and biologics. AIT demonstrates efficacy for the treatment of allergic asthma. Approved biologics for asthma management include using various interleukin antagonists and anti\u2010immunoglobulin E, with Tezepelumab offering promising treatments for both type\u20102 high and type\u20102 low asthma patients. Novel therapeutic candidates, such as Itepekimab and depemokimab, have demonstrated promising results in a Phase 2 clinical trial in moderate\u2010to\u2010severe asthma patients.<\/jats:p>","DOI":"10.1111\/cea.70084","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:54:32Z","timestamp":1748998472000},"page":"773-783","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mechanisms and Treatment of Type 2 High and Low Asthma Endotypes"],"prefix":"10.1111","volume":"55","author":[{"given":"Timothy C.","family":"Chin\u2010See\u2010Chong","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper H.","family":"Kappen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"},{"name":"National Heart and Lung Institute Imperial College London  London UK"},{"name":"Asthma UK Centre in Allergic Mechanisms of Asthma  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Palmer","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute Imperial College London  London UK"},{"name":"Asthma UK Centre in Allergic Mechanisms of Asthma  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5242-1806","authenticated-orcid":false,"given":"Janice A.","family":"Layhadi","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute Imperial College London  London UK"},{"name":"Asthma UK Centre in Allergic Mechanisms of Asthma  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Shamji","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute Imperial College London  London UK"},{"name":"Asthma UK Centre in Allergic Mechanisms of Asthma  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-5416","authenticated-orcid":false,"given":"Johanna P. M.","family":"van der Valk","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"},{"name":"Department of Pulmonary Diseases Erasmus Medical Centrum  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"10","key":"e_1_2_12_2_1","first-page":"1622","article-title":"Genetic and Environmental Factors Associated With Bronchial Asthma","volume":"74","author":"Tanimoto Y.","year":"2016","journal-title":"Nihon Rinsho"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2019.04.007"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2016.04.011"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.03.010"},{"key":"e_1_2_12_6_1","first-page":"105","article-title":"Allergen Immunotherapy Guidelines Part 1: Systematic Reviews","volume":"2017","author":"Muraro A. R. G.","year":"2017","journal-title":"European Academy of Allergy and Clinical Immunology"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.09.004"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.2310\/7480.2005.00016"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889\u20108561(03)00104\u20108"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R110.197046"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.03.015"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.586078"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217930"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.05.014"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01147"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00483-2022"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.05.011"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081428"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14196"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00309-2020"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.07.003"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S49306"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.031468"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14136"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S153097"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14222"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753466618810192"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.49"},{"key":"e_1_2_12_29_1","unstructured":"FDA (Food and Drugs Administration) \u201cApproved Drug Products: XOLAIR (omalizumab) Injection for Subcutaneous Use \u201d2024."},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S180846"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104215"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.03.010"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1586\/ers.09.7"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-019-0337-2"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-019-00345-7"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009705"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00149812"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01501-2015"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-014-0107-z"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622317690494"},{"issue":"3","key":"e_1_2_12_41_1","first-page":"101","article-title":"Effectiveness and Pharmacoeconomic Analysis of the Treatment of Severe Asthma With Omalizumab in Clinical Practice","volume":"43","author":"Martinez\u2010Moragon E.","year":"2019","journal-title":"Farmacia Hospitalaria"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.016"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.035"},{"issue":"4","key":"e_1_2_12_44_1","article-title":"Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab","volume":"9","author":"Menzella F.","year":"2021","journal-title":"Biomedicine"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61380-3"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_86_19"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00004013"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxp102"},{"key":"e_1_2_12_50_1","unstructured":"FDA (Food and Drugs Administration) \u201cApproved Drug Products: NUCALA (mepolizumab) Injection for Subcutaneous Use \u201d2019."},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30051-5"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-085OC"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201707-1323OC"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.032"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.12.997"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14544"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1371"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20102600(18)30406\u20105"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1065-3"},{"key":"e_1_2_12_65_1","unstructured":"Sanofi Evaluation of Supilumab in Patients with Persistent Asthma (Liberty Asthma Quest) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02414854. NLM identifier: NCT02414854. accessed 10 Apr 2019."},{"key":"e_1_2_12_66_1","unstructured":"Sanofi \u201cEvaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE) \u201dhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02528214. NLM identifier: NCT02528214. accessed 10 Apr 2019."},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30265-X"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30184-X"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.11.021"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.01.001"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmec.2012.09.003"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094369"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01526-6"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221095540"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414482"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.16237"},{"issue":"1","key":"e_1_2_12_77_1","article-title":"Allergen Injection Immunotherapy for Seasonal Allergic Rhinitis","author":"Calderon M. A.","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410702"},{"key":"e_1_2_12_79_1","unstructured":"A. R. G.Muraro \u201cAllergen Immunotherapy Guidelines Part 1: Systematic Reviews \u201d2017."},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00092"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0895\u20104356(00)00349\u20108"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.16.1744"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.019"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3964"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202209-1708OC"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1614397"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2021.747323"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13138"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.02.014"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024257"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14297"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2406673"},{"key":"e_1_2_12_93_1","volume-title":"In Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)","author":"An Open\u2010Label Extension Study of GSK3511294 (Depemokimab)","year":"2024"},{"key":"e_1_2_12_94_1","unstructured":"M.CroftandNational Institutes of Health (U.S.). Immunology Interest Group \u201cOX40 Costimulatory Signals and the Control of CD4 and CD8 T\u2010Cells [Two\u2010Dimensional Moving Image]. Bethesda Md.: National Institutes of Health \u201d2007 http:\/\/videocast.nih.gov\/launch.asp?13794."},{"key":"e_1_2_12_95_1","volume-title":"Madame Curie Bioscience Database","author":"Croft M.","year":"2013"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.031"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110297"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cea.70084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T09:22:49Z","timestamp":1764148969000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.70084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/cea.70084"],"URL":"https:\/\/doi.org\/10.1111\/cea.70084","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"2024-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}